David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
576
DELISTED
Dynavax Technologies
DVAX
| $38.9M | 0.04% |
2,025,547
+1,053,737
| +108% | +$14M |
|
|
CMA
577
DELISTED
Comerica
CMA
| $38.7M | 0.04% |
481,185
-297,623
| -38% | -$21.4M |
|
|
X
578
PUT
DELISTED
US Steel
X
| $38.7M | 0.03% |
1,761,000
-79,900
| -4% | -$2M |
|
579
monday.com
MNDY
$3.98B
| $38.6M | 0.03% |
+118,440
| New | +$34.8M |
|
|
STMP
580
PUT
DELISTED
Stamps.com, Inc.
STMP
| $38.5M | 0.03% |
116,600
-25,300
| -18% | -$8.03M |
|
581
CALL
Pfizer
PFE
$159B
| $38.4M | 0.03% |
893,000
-417,000
| -32% | -$18.5M |
|
582
PagerDuty
PD
$956M
| $38.1M | 0.03% |
920,782
+221,857
| +32% | +$9.4M |
|
583
Asana
ASAN
$2.25B
| $38.1M | 0.03% |
+367,218
| New | +$30.5M |
|
584
PUT
Union Pacific
UNP
$184B
| $38.1M | 0.03% |
194,200
+146,800
| +310% | +$31.7M |
|
585
CALL
Morgan Stanley
MS
$336B
| $38M | 0.03% |
390,000
-219,900
| -36% | -$21.8M |
|
586
UnitedHealth
UNH
$358B
| $37.9M | 0.03% |
97,036
-65,875
| -40% | -$27.3M |
|
587
Knowles
KN
$2.78B
| $37.9M | 0.03% |
2,021,190
-103,160
| -5% | -$2.02M |
|
588
Texas Capital Bancshares
TCBI
$4.26B
| $37.8M | 0.03% |
630,214
-94,539
| -13% | -$5.89M |
|
589
Crocs
CROX
$6.03B
| $37.7M | 0.03% |
262,992
+159,694
| +155% | +$21.9M |
|
590
IBM
IBM
$218B
| $37.7M | 0.03% |
283,678
+116,519
| +70% | +$15.6M |
|
591
PTC
PTC
$16.7B
| $37.6M | 0.03% |
+314,078
| New | +$41.9M |
|
592
CALL
Paycom
PAYC
$10.3B
| $37.4M | 0.03% |
75,400
+42,800
| +131% | +$19.1M |
|
593
Bruker
BRKR
$8.68B
| $37.3M | 0.03% |
478,162
-22,232
| -4% | -$1.85M |
|
594
FMC
FMC
$1.41B
| $37.2M | 0.03% |
405,852
-121,439
| -23% | -$12M |
|
595
Genuine Parts
GPC
$18.7B
| $37.1M | 0.03% |
305,794
+217,257
| +245% | +$27.1M |
|
596
Bilibili
BILI
$6.91B
| $37M | 0.03% |
558,917
+474,455
| +562% | +$40.6M |
|
597
VF Corp
VFC
$5.63B
| $37M | 0.03% |
551,629
+220,104
| +66% | +$16.9M |
|
598
CALL
Expedia Group
EXPE
$40.7B
| $36.9M | 0.03% |
225,000
-50,000
| -18% | -$7.73M |
|
|
599
PUT
Bilibili
BILI
$6.91B
| $36.8M | 0.03% |
555,500
-122,500
| -18% | -$10.5M |
|
600
PUT
Procter & Gamble
PG
$341B
| $36.7M | 0.03% |
262,800
-24,900
| -9% | -$3.53M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.